Correlation between computed tomographic density of lymph node metastases and response to cisplatin-based chemotherapy in patients with head and neck squamous cell carcinoma in an area in which betel quid chewing is prevalent

Cancer

Volumn 78, Issue 9, 1996, Pages 1972-1979

  Wang, Hung Ming ^a,b   Ng, Shu Hang ^b   Wang, Cheng Hsu ^a   Liaw, Chuang Chi ^a   Tsai, Ming Hsui ^b   Lai, Gi Ming ^b  

^a Lin Kou Medical Center   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

betel quid; cervical lymph node; chemotherapy; head and neck neoplasms

Indexed keywords

CISPLATIN;

ADJUVANT THERAPY; ARTICLE; BETEL NUT; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER RISK; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; HEAD AND NECK CANCER; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ARECA; CARCINOMA, SQUAMOUS CELL; CISPLATIN; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK; PLANTS, MEDICINAL; PROSPECTIVE STUDIES;

EID: 0029802483     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19961101)78:9<1972::AID-CNCR19>3.0.CO;2-V     Document Type: Article

References (38)

1. Department of Health, the Executive Yuan, R.O.C. Cancer Registry Annual Report in Taiwan Area, 1990. June 1994.
2. Dimery IW, Hong WK. Overview of combined modality therapies for head and neck cancer. J Natl Cancer Inst 1993;85:95-111.
3. Schantz SP, Harrison LB, Hong WK. Cancer of head and neck. In: Devita VT, Hellman S, Rosenberg SA, editors. Cancer: principles & practice of oncology. 4th edition. Philadelphia: J.B. Lippincott, 1993:574-630.
4. Toohill RJ, Anderson T, Byhardt RW, Cox JD, Duncavage JA, Grossman TW, et al. Cisplatin and fluorouracil as neoadjuvant chemotherapy in head and neck cancer. Arch Otolaryngol Head Neck Surg 1987;113:758-61.
5. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991;324:1685-90.
6. Paccagnella A, Orlando A, Marchiori C, Zorat PL, Cavaniglia G, Sileni VC, et al. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo. J Natl Cancer Inst 1994;86:265-72.
7. Martin M, Malaurie E, Langlet PM, Vergnes L, Lelievre G, Mazeron JJ, et al. A randomized prospective study of CDDP and 5-FU as neoadjuvant chemotherapy in head and neck cancer: a final report. Proc Am Soc Clin Oncol 1995;14:294.
8. Jacobs C, Goffmet DR, Goffinet L, Kohler M, Fee WE. Chemotherapy as a substitute for surgery in the treatment of advanced resectable head and neck cancer. Cancer 1987; 60:1178-83.
9. Pfister DG, Strong E, Harrison L, Haines IE, Pfister DA, Sessions R, et al. Larynx preservation with combined chemotherapy and radiation therapy in advanced but resectable head and neck cancer. J Clin Oncol 1991;9:850-9.
10. Cognetti F, Pinnaro P, Ruggeri EM, Carlini P, Perrino A, Impiombato FA, et al. Prognostic factors for chemotherapy response and survival using combination chemotherapy as initial treatment of advanced head and neck squamous cell cancer. J Clin Oncol 1989;7:829-37.
11. Wolf GT, Makuch RW, Baker SR. Predictive factors for tumor response to preoperative chemotherapy in patients with head and neck squamous carcinoma: the head and neck contracts program. Cancer 1984;54:2869-77.
12. Clavel M, Mansour AR. Head and neck cancer: prognostic factors for response to chemotherapy. Eur J Cancer 1991;27:349-56.
13. Wang HM, Wang CH, Chen JS, Chang HK, Kiu MC, Liaw CC, et al. Cisplatin and 5-FU as neoadjuvant chemotherapy: predicting response in head and neck squamous cell cancer. J Formos Med Assoc 1995;94:87-94.
14. Munck JN, Cvitkovic E, Piekarski JD, Benhamou E, Recondo G, Bachouchi M, et al. Computed tomographic density of metastatic lymph nodes as a treatment-related prognostic factor in advanced head and neck cancer. J Natl Cancer Inst 1991;83:569-75.
15. Janot F, Cvitkovic E, Piekarski JD, Sigal R, Armand JP, Bensmaine A, et al. Correlation between nodal density in contrasted scans and response to cisplatin-based chemotherapy in head and neck squamous cell cancer: a prospective validation. Head Neck 1993;15:222-9.
16. Chong KM. Betel nut chewing and mouth cancer in Taiwan. Observation of the oral mucosa in the betel nut chewers. J Formos Med Assoc 1966;65:79-85.
17. Kwan HW. A statistical study on oral carcinomas in Taiwan with emphasis on the relationship with betel nut chewing: a preliminary report. J Formos Med Assoc 1976;75:497-505.
18. Kuo MYP, Jeng JH, Chiang CP, Hahn LJ. Mutations of Ki-ras oncogene codon 12 in betel quid chewing-related human oral squamous cell carcinoma in Taiwan. J Oral Pathol Med 1994;23:70-4.
19. Ko YC. A review of betel quid chewing and its health effects in Taiwan. Symposium on betel quid chewing and its health effect [in Chinese] [abstract]. Kaohsiung R.O.C. 1993;11-2.
20. Johnson JT, Barnes L, Myers EN. The extracapsular spread of tumors in cervical node metastasis. Arch Otolaryngol 1981;107:725-9.
21. Snow GB, Annyas AA, VanSlooten AE, Bartelink H, Hart AAM. Prognostic factors of neck node metastasis. Clin Otolaryngol 1982;7:185-92.
22. Johnson JT, Myers EN, Bedetti CD, Barnes EL, Schramm VL, Thearle PB. Cervical lymph node metastases. Arch Otolaryngol Head Neck Surg 1985;111:534-7.
23. Som PM. Lymph nodes. In: Som PM, Curtin HD, editors. Head and neck imaging. 3rd edition. St. Louis: Mosby-Year Book, Inc., 1996:772-93.
24. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207-14.
25. American Joint Committee on Cancer. Manual for staging of cancer. 3rd edition. Philadelphia: J.B. Lippincott, 1988.
26. Muir C, Weiland L. Upper aerodigestive tract cancer. Cancer 1995;75:147-53.
27. Rooney M, Kish J, Jacobs J, Kinzie J, Weaver A, Crissman J, et al. Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin. Cancer 1985;55:1123-8.
28. Ko YC, Chiand TA, Chang SJ, Hsieh SF. Prevalence of betel quid chewing habit in Taiwan and related sociodemographic factors. J Oral Pathol Med 1992;21:261-4.
29. Bachaud JM, David JM, Shubinski RF, Perineau D, Boussin G, Serrano E, et al. Predictive factors of a complete response to and adverse effects of a CDDP-5-FU combination as primary therapy for head and neck squamous carcinomas. J Laryngol Otol 1993;107:924-30.
30. Thyss A, Schneider M, Santini J, Caldani C, Vallicioni I, Chauvel P, et al. Induction chemotherapy with cisplatin and 5-fluorouracil for squamous cell carcinoma of the head and neck. Br J Cancer 1986;54:755-60.
31. Moreau P, Goffard Y, Collignon J. Computed tomography of metastatic lymph nodes: a clinical, computed tomographic, pathologic correlative study. Arch Otolaryngol Head Neck Surg 1990;116:1190-3.
32. Rainer T, Ofner G, Marckhgott E. Ultrasound diagnosis of regional lymph node metastasis of the neck in patients with head-neck neoplasm: sono-morphologic criteria and diagnostic accuracy. Laryngorhinootologie 1993;72:73-7.
33. Devita VT. Principles of chemotherapy. In: Devita VT, Hellman S, Rosenberg SA, editors. Cancer: principles & practice of oncology. 4th edition. Philadelphia: J.B. Lippincott, 1993;236-92.
34. Goldie JH, Goldman AJ. A mathematic model for relating the drug sensitivity of tumors to the spontaneous mutation rate. Cancer Treat Rep 1979;63:1727-33.
35. Million RR, Cassisi NJ, Mancuso AA, Stringer SP, Mendenhall WM, Parsons JT. Management of the neck for squamous cell carcinoma. In: Million RR, Cassisi NJ, editors. Management of head and neck cancer: a multidisciplinary approach. 2nd edition. Philadelphia: J.B. Lippincott, 1994:75-142.
36. Mancuso AA, Dillon WP. The neck. Radiol Clin North Am 1989;27:407-34.
37. Yousem DM, Som PM, Hackney DB, Schwaibold F, Hendrix RA. Central nodal necrosis and extracapsular neoplastic spread in cervical lymph nodes: MR imaging versus CT. Radiology 1992;182:753-9.
38. Davis RK, Stoker K, Harker G, Davis K, Gibbs FA, Harnsberger HR, et al. Prognostic indicators in head and neck cancer patients receiving combined therapy. Arch Otolaryngol Head Neck Surg 1989;115:1443-6.